公司資料

Lyra Therapeutics 股價、新聞與催化劑

股票代碼:: LYRA
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股票表現

0.01 USD (+2400.00%)

收盤價

最後更新: 2026年8月21日

—

市值

股價為何變動

As of Aug 21, 2026, LYRA closed up 2400.0% at $0.0100. No new same-company headline was identified in the current news window.

公司概覽

業務概覽

Lyra Therapeutics is an otolaryngology company focused on chronic rhinosinusitis and upper-airway disease. Its platform uses localized delivery to treat difficult ENT conditions.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Lyra sits in specialty biotechnology.

商業模式特徵

The company depends on clinical validation, delivery technology, and the ability to build a niche ENT franchise.

生技產業定位

Lyra is a niche ENT catalyst name whose stock is driven by clinical and regulatory progress.

未來催化劑

Lyra’s catalysts are its GI-surgery and reflux platform, along with any commercial update that shows the device base is still growing. The story is about procedure adoption more than binary events.